CAMBRIDGE, Mass. - Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company with a market capitalization of $59.31 million, has entered into a clinical supply agreement with Regeneron ...
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
This year, the sisters produced more than 1,000 jars of kuih kapit and about 30 jars of kuih ros, a remarkable achievement for the dedicated group. They spend at least six hours daily on production, e ...
CapitaLand Integrated Commercial Trust (OTCPK:CPAMF) Q4 2024Management ViewCEO Tony Tan highlighted that CapitaLand ...
West Virginia's Tucker DeVries will have surgery for an upper-body injury and miss the rest of the season. His father, West ...
Hosted on MSN3d
Spain moves to slash working week to 37.5 hoursSpain's minority leftist government on Tuesday approved a plan to reduce the working week to 37.5 hours in one of the world's ...
Jalen Brunson had 42 points and 10 assists, and the New York Knicks beat the Houston Rockets 124-118. Brunson scored 17 ...
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback